Optical Coherence Tomography-Based Quantification of Photoreceptor Injury and Recovery in Vogt–Koyanagi–Harada Uveitis

REFERENCES

• Moorthy RS, Inomata H, Rao NA. Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol. 1995;39:265–292.
   PubMed Web of Science ®Google Scholar
• Rubsamen PE, Gass JD. Vogt–Koyanagi–Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991;109:682–687.
   PubMedGoogle Scholar
• Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt–Koyanagi–Harada disease. Retina. 2012;32:2061–2069.
   PubMed Web of Science ®Google Scholar
• Parc C, Guenoun JM, Dhote R, et al. Optical coherence tomography in the acute and chronic phases of Vogt–Koyanagi–Harada disease. Ocul Immunol Inflamm. 2005;13(2–3):225–227.
   PubMed Web of Science ®Google Scholar
• Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432–435.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A, Bacsal K. Spectrum of Vogt–Koyanagi–Harada disease in Singapore. Int Ophthalmol. 2007;27(2–3):137–142.
   PubMedGoogle Scholar
• Hou S, Du L, Lei B, et al. Genome-wide association analysis of Vogt–Koyanagi–Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3. Nat Genet. 2014;46:1007–1011.
   PubMed Web of Science ®Google Scholar
• Ng JY, Luk FO, Lai TY, et al. Influence of molecular genetics in Vogt–Koyanagi–Harada disease. J Ophthalmic Inflamm Infect. 2014;4:20.
   PubMedGoogle Scholar
• Lai TY, Chan RP, Chan CK, et al. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt–Koyanagi–Harada disease. Eye (Lond). 2009;23:543–548.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Al Tamimi M, Hemachandran S, et al. Prognostic factors for clinical outcomes in patients with Vogt–Koyanagi–Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91:e486–e493.
   PubMed Web of Science ®Google Scholar
• Gupta V, Gupta A, Gupta P, et al. Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt–Koyanagi–Harada disease. Am J Ophthalmol. 2009;147:148–153 e142.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Otani T, Kishi S. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt–Koyanagi–Harada disease. Am J Ophthalmol. 2007;144:260–265.
   PubMed Web of Science ®Google Scholar
• de Smet MD, Rao NA. Retinal cystoid spaces in acute Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol. 2005;140:962; author reply 962–963.
   PubMed Web of Science ®Google Scholar
• Ishihara K, Hangai M, Kita M, et al. Acute Vogt–Koyanagi–Harada disease in enhanced spectral-domain optical coherence tomography. Ophthalmology. 2009; 116:1799–1807.
   Google Scholar
• Lin D, Chen W, Zhang G, et al. Comparison of the optical coherence tomographic characters between acute Vogt–Koyanagi–Harada disease and acute central serous chorioretinopathy. BMC Ophthalmol. 2014;14:87.
   PubMed Web of Science ®Google Scholar
• Baek J, Park YH. Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy. Am J Ophthalmol. 2015;159:386–392.
   PubMed Web of Science ®Google Scholar
• Kashani AH, Cheung AY, Robinson J, et al. Longitudinal optical density analysis of subretinal fluid after surgical repair of rhegmatogenous retinal detachment. Retina. 2015;35:149–156.
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Ishikawa M, Yamaki K. Ultrastructural changes in rat eyes with experimental Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol. 2004;48:222–227.
   PubMed Web of Science ®Google Scholar
• Yamaki K, Kondo I, Nakamura H, et al. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res. 2000;71:361–369.
   PubMed Web of Science ®Google Scholar
• Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652.
   PubMed Web of Science ®Google Scholar
• Young M, Forooghian F. Serous index of pigment epithelial detachments in neovascular age-related macular degeneration predicts response to anti-vascular endothelial growth factor treatment. Ophthalmic Surg Lasers Imaging Retina. 2015;46:724–727.
   PubMed Web of Science ®Google Scholar
• Symes R, Young M, Forooghian F. Quantitative Assessment of Retinal Degeneration in Birdshot Chorioretinopathy Using Optical Coherence Tomography. Ophthalmic Surg Lasers Imaging Retina 2015 Nov 1;46(10):1009–1012.
   PubMed Web of Science ®Google Scholar
• Hangai M, Fujimoto M, Yoshimura N. Features and function of multiple evanescent white dot syndrome. Arch Ophthalmol. 2009;127:1307–1313.
   PubMedGoogle Scholar
• Forooghian F, Stetson PF, Gross NE, et al. Quantitative assessment of photoreceptor recovery in atypical multiple evanescent white dot syndrome. Ophthalmic Surg Lasers Imaging. 2010; 41 Suppl:S77–S80.
   PubMedGoogle Scholar
• Li D, Kishi S. Restored photoreceptor outer segment damage in multiple evanescent white dot syndrome. Ophthalmology. 2009;116:762–770.
   PubMed Web of Science ®Google Scholar
• Keane PA, Allie M, Turner SJ, et al. Characterization of birdshot chorioretinopathy using extramacular enhanced depth optical coherence tomography. JAMA Ophthalmol. 2013;131:341–350.
   PubMed Web of Science ®Google Scholar
• Birnbaum AD, Fawzi AA, Rademaker A, et al. correlation between clinical signs and optical coherence tomography with enhanced depth imaging findings in patients with birdshot chorioretinopathy. JAMA Ophthalmol. 2014;132:929–935.
   PubMed Web of Science ®Google Scholar
• Forooghian F, Gulati N, Jabs DA. Restoration of retinal architecture following systemic immunosuppression in birdshot chorioretinopathy. Ocul Immunol Inflamm. 2010;18:470–471.
   PubMed Web of Science ®Google Scholar